A Path to Preventing Cognitive Impairment Due to Alzheimer's Disease

episode

Neurology Minute not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-22-2026 7PM EDT 4 min · 22 Sep 2026 · NPR News Now

US-Iran Talks on Sidelines of UN Summit, Chipmakers Rally, More 7 min · 22 Sep 2026 · Bloomberg News Now

7PM ET 09/22/2026 Newscast 3 min · 22 Sep 2026 · Fox News Hourly Update

Dentists Are Making Millions From This Lie - Dr. Ellie Phillips EXPOSES the dental industry 1h 5m · 22 Sep 2026 · Redacted News

Inside Big Brother: Nasty Nick (Ep 1) 39 min · 22 Sep 2026 · The Rest Is Entertainment

Jon Ronson on Conspiracy, Masculinity and Writing 1h 46m · 22 Sep 2026 · The Blindboy Podcast

Report any issue

Source

Recorded16 Apr 2026

Publisherneurologyminute.libsyn.com ↗

Handlerec:17889836

Show notes

Dr. Greg Cooper and Dr. Eric Reiman discuss emerging antibody therapies for preclinical Alzheimer's disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care. Show citation: Reiman EM, Alexander RC, Langbaum JB, et al. A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA. Lancet Neurol. 2026;25(3):268-278. doi:10.1016/S1474-4422(25)00483-1

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in